Daniel Rosenbaum

Title: The Innovations of Daniel Rosenbaum

Introduction

Daniel Rosenbaum is an accomplished inventor based in Dallas, Texas. He has made significant contributions to the field of science, particularly in the development of compounds that target the type-2 orexin receptor (OX2R). With a total of three patents to his name, Rosenbaum's work is paving the way for advancements in health and wellness.

Latest Patents

Rosenbaum's latest patents focus on OX2R compounds and their methods and compositions for agonizing the type-2 orexin receptor in cells that are determined to be in need thereof. The general method involves administering a cyclic guanidinyl OX2R agonist to a subject and detecting the resultant enhanced wakefulness or increased resistance to diet-induced accumulation of body fat. Additionally, his work addresses abbreviated recovery from general anesthesia or jet lag, showcasing the potential impact of his innovations on everyday life.

Career Highlights

Rosenbaum is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His dedication to innovation and scientific inquiry has established him as a notable figure in his field.

Collaborations

Some of his notable coworkers include Jef De Brabander and Qiren Liang, who contribute to the collaborative environment that fosters innovation and research excellence.

Conclusion

Daniel Rosenbaum's contributions to the field of science through his patents on OX2R compounds highlight his role as a leading inventor. His work not only advances scientific understanding but also has the potential to improve health outcomes for many individuals.